FDA Warning Letter — Jamol Laboratories, Inc.

Case 654464 — FEI 2211383

The FDA took a Warning Letter action against Jamol Laboratories, Inc. on July 13, 2023 (Emerson, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Jamol Laboratories, Inc.
Date
July 13, 2023
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Emerson, NJ (United States)